Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus. [electronic resource]
- Value in health regional issues May 2020
- 157-163 p. digital
Publication Type: Journal Article
2212-1102
10.1016/j.vhri.2019.09.003 doi
Blood Pressure--drug effects Cardiovascular Diseases--economics Cohort Studies Cost-Benefit Analysis--statistics & numerical data Humans Hypertension--drug therapy Markov Chains Quality-Adjusted Life Years Saudi Arabia--epidemiology Time Treatment Outcome